A retrospective cohort study assessing the incidence, treatment sequence, duration and anticoagulation-associated indication with the concomitant use of Enzalutamide and anticoagulation
Latest Information Update: 14 Sep 2021
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Dalteparin sodium (Primary) ; Enoxaparin sodium (Primary) ; Enzalutamide (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Atrial fibrillation; Deep vein thrombosis; Pulmonary embolism
- Focus Therapeutic Use
Most Recent Events
- 14 Sep 2021 New trial record
- 25 Aug 2021 Results presented at the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management